Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Leukemia, Myeloid, Acute 11Myelodysplastic Syndromes 9Lymphoma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia 6Hematologic Neoplasms 6Neuroblastoma 4Neoplasms 4Lymphoma, Non-Hodgkin 4Leukemia, Biphenotypic, Acute 4Leukemia, B-Cell 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Melanoma 3Leukemia, Lymphoid 3Hodgkin Disease 3Hematologic Diseases 3Sarcoma 2Rhabdoid Tumor 2Recurrence 2Preleukemia 2Precancerous Conditions 2Osteosarcoma 2Neoplasms, Germ Cell and Embryonal 2Neoplasms by Histologic Type 2Multiple Myeloma 2Lymphoproliferative Disorders 2Lymphatic Diseases 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myeloid 2

Interventions

Rituximab 45Cyclophosphamide 38ibrutinib 22fludarabine 22acalabrutinib 21venetoclax 20zanubrutinib 17Lenalidomide 17Bendamustine Hydrochloride 17obinutuzumab 16fludarabine phosphate 14Magnetic Resonance Spectroscopy 14Cytarabine 14Specimen Handling 13CT-P10 13pirtobrutinib 12Biopsy 12glofitamab 10Etoposide 10Whole-Body Irradiation 9Vincristine 7Peripheral Blood Stem Cell Transplantation 7Mycophenolic Acid 7Melphalan 7Doxorubicin 7brexucabtagene autoleucel 6Cyclosporine 6orelabrutinib 5Methotrexate 5Immunotherapy, Adoptive 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Mantle-Cell × Mesna × 1 year × Clear all
NCT00878254 2025-07-23

Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma

University of Miami

Phase 2 Completed
25 enrolled 14 charts
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡